2017
DOI: 10.1007/s10815-017-0935-1
|View full text |Cite
|
Sign up to set email alerts
|

The effect of follicle size and homogeneity of follicular development on the morphokinetics of human embryos

Abstract: Purpose Our aim was to investigate follicular size (large, ≥17 mm and small, <17 mm) at the time of OPU and homogeneity of follicular development (homogenous development: follicles being present in a homogenous spread of all sizes; heterogeneous: a predominance of small and large follicles) by analysing the morphokinetics of embryo development. Methods In this prospective cohort study, 2526 COCs belonging to 187 patients were cultured to day 5. Embryos were evaluated morphokinetically. Four subgroups were defi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
13
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 21 publications
(18 citation statements)
references
References 34 publications
3
13
0
Order By: Relevance
“…It was conducted in a private IVF clinic between July 2014 and September 2015 and the analysis was based on 2495 COCs belonging to 184 patients, with culture until day 5. Our previous study on follicular size and morphokinetics analysed 2526 oocytes [ 1 ]. However, in this study three patients and their 31 oocytes were excluded from the expression analysis because their CC samples did not give interpretable results due to technical issues.…”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations
“…It was conducted in a private IVF clinic between July 2014 and September 2015 and the analysis was based on 2495 COCs belonging to 184 patients, with culture until day 5. Our previous study on follicular size and morphokinetics analysed 2526 oocytes [ 1 ]. However, in this study three patients and their 31 oocytes were excluded from the expression analysis because their CC samples did not give interpretable results due to technical issues.…”
Section: Methodsmentioning
confidence: 99%
“…The patients presented various infertility causes, all protocols were approved by the institutional review board and all patients gave their informed consent prior to their inclusion in the study. Patients were selected with inclusion criteria as similar as possible to the first part of the study [ 1 ]. Furthermore, the inclusion criteria specified good prognosis patients with at least 8 COCs in order to provide us with a sufficient number of blastocysts for statistical analyses.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…The stimulation protocols have been outlined previously [14]. For ovarian stimulation, gonadotropin-releasing hormone (GnRH) analogue suppression (short or long), GnRH antagonist protocol and recombinant follicle stimulating hormone (rFSH) or a combination of rFSH and recombinant luteinizing hormone (rLH) (Luveris; Merck, Switzerland) or human menopausal gonadotropin (HMG) (HMG, Ferring, Switzerland) were used.…”
Section: Ovarian Stimulationmentioning
confidence: 99%
“…The rate of both MI and GV oocytes negatively impacted on the fertilization of the MII oocytes from the same cohort. In fact, increasing incidence of mature oocytes has been correlated with increasing fertilization rate (Halvaei et al, 2012;Kahraman et al, 2017). The oocyte competence depends on a multiplicity of factors; one of them is the ability to generate normal Ca 2+ oscillation response induced by sperm penetration, that develops during the final stages of oocyte growth and maturation and is essential for promoting oocyte activation and fertilization initiation; thereafter MII oocytes that did not reach fully completed cytoplasmic maturity could have impairment in the acquisition of developmental competence (Cheung et al, 2000) The fertilization of mature oocytes derived from cycles with heterogeneous follicular development can lead to abnormal early embryo development, with embryos with significantly more cleavages and lower blastocyst quality (Halvaei et al, 2012;Kahraman et al, 2017).…”
Section: Clinical Outcomesmentioning
confidence: 99%